KR20230136643A - Al 아밀로이드증 치료 방법 - Google Patents

Al 아밀로이드증 치료 방법 Download PDF

Info

Publication number
KR20230136643A
KR20230136643A KR1020237029277A KR20237029277A KR20230136643A KR 20230136643 A KR20230136643 A KR 20230136643A KR 1020237029277 A KR1020237029277 A KR 1020237029277A KR 20237029277 A KR20237029277 A KR 20237029277A KR 20230136643 A KR20230136643 A KR 20230136643A
Authority
KR
South Korea
Prior art keywords
patient
meters
treatment
amyloidosis
months
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237029277A
Other languages
English (en)
Korean (ko)
Inventor
진 키니
와그너 자고
라디카 트리푸라네니
캐롤 카프
Original Assignee
프로테나 바이오사이언시즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로테나 바이오사이언시즈 리미티드 filed Critical 프로테나 바이오사이언시즈 리미티드
Publication of KR20230136643A publication Critical patent/KR20230136643A/ko
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Chemical Treatment Of Metals (AREA)
KR1020237029277A 2021-01-29 2022-01-29 Al 아밀로이드증 치료 방법 Pending KR20230136643A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163143728P 2021-01-29 2021-01-29
US63/143,728 2021-01-29
PCT/IB2022/050785 WO2022162625A1 (en) 2021-01-29 2022-01-29 Methods of treating al amyloidosis

Publications (1)

Publication Number Publication Date
KR20230136643A true KR20230136643A (ko) 2023-09-26

Family

ID=80222587

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237029277A Pending KR20230136643A (ko) 2021-01-29 2022-01-29 Al 아밀로이드증 치료 방법

Country Status (13)

Country Link
US (1) US20250084153A1 (https=)
EP (1) EP4284829A1 (https=)
JP (1) JP2024505923A (https=)
KR (1) KR20230136643A (https=)
CN (1) CN117098775A (https=)
AU (1) AU2022213010A1 (https=)
CA (1) CA3206326A1 (https=)
CL (1) CL2023002236A1 (https=)
IL (1) IL304755A (https=)
JO (1) JOP20230172A1 (https=)
MX (1) MX2023008835A (https=)
TW (1) TW202332465A (https=)
WO (1) WO2022162625A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021552135A1 (en) 2019-03-05 2022-08-31 Prothena Biosciences Ltd Methods of treating al amyloidosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018005967A1 (en) * 2016-06-30 2018-01-04 Prothena Therapeutics Limited Compositions for treating amyloidosis
US11382974B2 (en) * 2017-08-01 2022-07-12 The Trustees Of Columbia University In The City Of New York Methods and compositions for treatment of amyloid deposition diseases
PH12021552135A1 (en) * 2019-03-05 2022-08-31 Prothena Biosciences Ltd Methods of treating al amyloidosis

Also Published As

Publication number Publication date
US20250084153A1 (en) 2025-03-13
EP4284829A1 (en) 2023-12-06
JOP20230172A1 (ar) 2023-07-27
IL304755A (en) 2023-09-01
CL2023002236A1 (es) 2024-02-09
CN117098775A (zh) 2023-11-21
AU2022213010A1 (en) 2023-08-17
WO2022162625A1 (en) 2022-08-04
AU2022213010A9 (en) 2024-09-26
TW202332465A (zh) 2023-08-16
CA3206326A1 (en) 2022-08-04
JP2024505923A (ja) 2024-02-08
MX2023008835A (es) 2023-09-08

Similar Documents

Publication Publication Date Title
US12240894B2 (en) Methods of treating AL amyloidosis
JP2024127990A (ja) アミロイドーシスを処置するための組成物
KR20230136643A (ko) Al 아밀로이드증 치료 방법
KR20240133743A (ko) Al 아밀로이드증 치료 방법
JP2024519450A (ja) 抗ガレクチン-9抗体及びその治療的使用
WO2025170969A1 (en) Methods of treating al amyloidosis
EA048260B1 (ru) Способы лечения al-амилоидоза
KR20230009431A (ko) 발작성 야간 혈색소뇨증의 치료를 위한 보체 인자 d 저해제를 단독으로 또는 항-c5 항체와 조합한 용도
HK40066935A (en) An antibody for use in methods of treating al amyloidosis
HK40066935B (en) An antibody for use in methods of treating al amyloidosis
WO2025166118A1 (en) Dosage and administration of anti-c5 antibodies for treating iga nephropathy (igan)

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20230828

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250131

Comment text: Request for Examination of Application